Patents by Inventor Kenji Namoto

Kenji Namoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
    Patent number: 9290485
    Abstract: The invention relates to compound of the formula I in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    Type: Grant
    Filed: July 29, 2011
    Date of Patent: March 22, 2016
    Assignee: NOVARTIS AG
    Inventors: Trixi Brandl, Stefanie Flohr, Sebastian Kopec, Julie Lachal, Christian Markert, Kenji Namoto, Perle Nganga, Bernard Pirard, Martin Renatus, Richard Sedrani, Thomas Zoller
  • 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
    Publication number: 20140378474
    Abstract: The invention relates to a compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    Type: Application
    Filed: January 25, 2013
    Publication date: December 25, 2014
    Applicant: NOVARTIS AG
    Inventors: Stefanie Flohr, Christian Markert, Kenji Namoto, Bernard Pirard
  • Aminopyridine derivatives as plasma kallikrein inhibitors
    Publication number: 20140350034
    Abstract: The invention relates to compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    Type: Application
    Filed: January 25, 2013
    Publication date: November 27, 2014
    Applicant: NOVARTIS AG
    Inventors: Trixi Brandl, Stefanie Flohr, Christian Markert, Kenji Namoto, Bernard Pirard, Martin Renatus
  • ORGANIC COMPOUNDS
    Publication number: 20130012485
    Abstract: Compounds of the formula (I) are provided: wherein V, W, X, Y, Z, R3, R4, R5, R6, R7 and m are as defined in the specification; and pharmaceutically acceptable salts and prodrugs thereof. The compounds may be useful in the treatment or prevention of various diseases and conditions in which dipeptidylpeptidase-IV (DPP-IV) is implicated.
    Type: Application
    Filed: December 20, 2007
    Publication date: January 10, 2013
    Inventors: Daniel Kaspar Bäschlin, Richard Sedrani, Stefanie Flohr, Kenji Namoto, Nils Ostermann, Finton Sirockin, François Gessier, Garry Fenton, Mandy Christine Beswick, David Edward Clark, Bohdan Waszkowycz
  • ORGANIC COMPOUNDS
    Publication number: 20120077787
    Abstract: New compounds of the Formula (I): for the treatment of non-insulin-dependent diabetes mellitus.
    Type: Application
    Filed: December 6, 2011
    Publication date: March 29, 2012
    Applicant: NOVARTIS AG
    Inventors: Daniel Kaspar Baeschlin, Nils OSTERMANN, Francois GESSIER, Finton SIROCKIN, Kenji NAMOTO
  • N-((6-AMINO-PYRIDIN-3-YL)METHYL)-HETEROARYL-CARBOXAMIDES
    Publication number: 20120035168
    Abstract: The invention relates to compound of the formula I in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    Type: Application
    Filed: July 29, 2011
    Publication date: February 9, 2012
    Applicant: NOVARTIS AG
    Inventors: Trixi BRANDL, Stefanie FLOHR, Sebastian KOPEC, Julie LACHAL, Christian MARKERT, Kenji NAMOTO, Perle NGANGA, Bernard PIRARD, Martin RENATUS, Richard SEDRANI, Thomas ZOLLER
  • Organic compounds
    Patent number: 8097617
    Abstract: New compounds of the Formula (I): for the treatment of non-insulin-dependent diabetes mellitus.
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: January 17, 2012
    Assignee: Novartis AG
    Inventors: Daniel Kaspar Baeschlin, Nils Ostermann, Francois Gessier, Finton Sirockin, Kenji Namoto
  • Organic compounds
    Patent number: 7888351
    Abstract: The present invention relates to compounds of the formula; and their use in therapy.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: February 15, 2011
    Assignee: Novartis AG
    Inventors: Daniel Kaspar Baeschlin, Garry Fenton, Kenji Namoto, Nils Ostermann, Richard Sedrani, Finton Sirockin
  • ORGANIC COMPOUNDS
    Publication number: 20110034462
    Abstract: The present invention relates to compounds of the formula; and their use in therapy.
    Type: Application
    Filed: October 15, 2010
    Publication date: February 10, 2011
    Inventors: Daniel Kaspar Baeschlin, Garry Fenton, Kenji Namoto, Nils Ostermann, Richard Sedrani, Finton Sirockin
  • ORGANIC COMPOUNDS
    Publication number: 20090281069
    Abstract: The present invention relates to compounds of the formula; and their use in therapy.
    Type: Application
    Filed: April 10, 2007
    Publication date: November 12, 2009
    Inventors: Daniel Kaspar Baeschlin, Garry Fenton, Kenji Namoto, Nils Ostermann, Richard Sedrani, Finton Sirockin
  • Organic Compounds
    Publication number: 20090253689
    Abstract: New compounds of the Formula (I): for the treatment of non-insulin-dependent diabetes mellitus.
    Type: Application
    Filed: March 29, 2007
    Publication date: October 8, 2009
    Inventors: Daniel Kaspar Baeschlin, Nils Ostermann, Francois Gessier, Finton Sirockin, Kenji Namoto
  • Cyclopropyl and cyclobutyl epothilone analogs
    Patent number: 7358266
    Abstract: The invention relates to cis- and trans-12, 13-cyclopropyl and 12,13-cyclobutyl epothilones of formula I to IV wherein Ar is a radical represented by the following structure: and the other radicals and symbols have the meanings as defined herein; to their chemical synthesis and biological evaluation; their use in the treatment of neoplastic diseases and to pharmaceutical preparations containing such compounds. The compounds described herein are potent tubulin polymerization promoters and cytotoxic agents.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: April 15, 2008
    Assignee: The Scripps Research Institute
    Inventors: Kyriacos C. Nicolaou, Kenji Namoto, Andreas Ritzen, Mitsuru Shoji, Trond Ulven, Karl-Heinz Altmann
  • Analogs of epothilone
    Patent number: 7169930
    Abstract: Designed epoxide and cyclopropane epothilone analogs with substituted side-chains are disclosed and characterized with respect to their biological activities against a series of human cancer cell lines. Among the several bioactive analogs, the epothilone B analog with a thiomethyl thiazole ring stands out as the most potent.
    Type: Grant
    Filed: August 4, 2003
    Date of Patent: January 30, 2007
    Assignee: The Scripps Research Institute
    Inventors: Kyriacos C. Nicolaou, Andreas Ritzen, Kenji Namoto
  • Analogs of epothilone
    Publication number: 20060293527
    Abstract: Designed epoxide and cyclopropane epothilone analogs with substituted side-chains are disclosed and characterized with respect to their biological activities against a series of human cancer cell lines. Among the several bioactive analogs, the epothilone B analog with a thiomethyl thiazole ring stands out as the most potent.
    Type: Application
    Filed: August 28, 2006
    Publication date: December 28, 2006
    Applicant: The Scripps Research Institute
    Inventors: Kyriacos Nicolaou, Andreas Ritzen, Kenji Namoto
  • Analogs of epothilone
    Publication number: 20040072870
    Abstract: Designed epoxide and cyclopropane epothilone analogs with substituted side-chains are disclosed and characterized with respect to their biological activities against a series of human cancer cell lines. Among the several bioactive analogs, the epothilone B analog with a thiomethyl thiazole ring stands out as the most potent.
    Type: Application
    Filed: August 4, 2003
    Publication date: April 15, 2004
    Applicant: The Scripps Research Institute
    Inventors: Kyriacos C. Nicolaou, Andreas Ritzen, Kenji Namoto
  • Cyclopropyl and cyclobutyl epothilone analogs
    Publication number: 20040039026
    Abstract: The invention relates to cis- and trans-12, 13-cyclopropyl and 12,13-cyclobutyl epothilones of formula I to IV 1
    Type: Application
    Filed: August 23, 2002
    Publication date: February 26, 2004
    Applicant: The Scripps Research Institute
    Inventors: Kyriacos C. Nicoloou, Kenji Namoto, Andreas Ritzen, Mitsuru Shoji, Trond Ulven, Karl-Heinz Altmann